Analystreport

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at Cantor Fitzgerald from $4.00 to $1.30.

Oncternal Therapeutics, Inc.  (ONCT) 
Last oncternal therapeutics, inc. earnings: 8/8 04:01 pm Check Earnings Report